Moneycontrol PRO

you are here: HomeNewsBusinessStocksNatco Pharma up 20% post US ruling on Copaxone patent case

SHOW NAMES

Trending Topics

Sensex Live Texmaco Rail Share Price John Cockerill India Shares GK Energy IPO Opens Today iValue Infosolutions IPO Day 2

business

Natco Pharma up 20% post US ruling on Copaxone patent case

"We are pleased to announce the US Court of Appeals for the Federal Circuit ruling, reversing a district court's finding related to Teva's US patent for Copaxone," Natco said in its filing.

first published: Jul 29, 2013 10:43 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347